MiR-129-5p represses the growth of liver cancer cells via regulating calcium/calmodulin-dependent protein kinase 4 (CAMK4) and thus suppresses the activation of mitogen-activated protein kinase (MAPK) signaling (Lin et al., 2019). Here, CAMK4 is linked to liver cancer.